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ABSTRACT  
The majority of states have implemented separate SCHIP (S-SCHIP) programs that 
significantly depart from Medicaid and resemble less comprehensive commercial 
products.  This difference in program design may result in S-SCHIP potentially being 
less responsive to children with special needs (CSHCNs).  This study explores how 
responsive insurers are to these higher than average needs.  We found that, with one 
exception, insurers did not agree on the coverage of any specific service, but overall they 
provided coverage beyond state limits and exclusions.  Second, the less acute the 
childhood condition, the more frequently insurers imposed exclusions.  Finally, in the 
majority of states, some insurers excluded services that arguably should have been 
covered according to the plan/contract language.  We conclude that SCHIP coverage at 
current levels may not be sufficient to care for CSHCNs, making external reviews of 
insurers’ coverage decisions and coordination with other sources of care important 
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INTRODUCTION 
How do private insurers that administer both the Medicaid and the separate State Children’s 
Health Insurance Program (SCHIP) programs make coverage decisions for SCHIP-enrolled 
children who have special health care needs (CSHCNs)?  Are there any differences between the 
benefits mandated under SCHIP and the implemented benefits as illustrated by insurers’ 
coverage decisions? What is the potential impact of these decisions for children’s access to care, 
particularly in comparison to the more comprehensive benefits provided to children enrolled in 
Medicaid?  This paper presents key findings from a study designed to answer these core 
questions. 
Enacted in 1997, SCHIP gives states the option to extend coverage to low-income children 
through a Medicaid expansion program, a separately-administered SCHIP program, or both.1  If 
a state chooses to implement a Medicaid expansion (M-SCHIP), all Medicaid rules apply.2   
Alternatively, if a state elects to establish a separately-administered program (S-SCHIP), it 
enjoys some flexibility in designing the program: it may follow Medicaid rules, or it can depart 
from these rules as long as the departure is within the broad limits of the law.3   As of FY 2003, 
all states participated in SCHIP.4    Fifteen states had separately-administered SCHIP programs, 
16 states (including D.C.) had Medicaid expansions, and 20 states had combination plans, 
covering a total of 5.9 million children.5   Of those, two-thirds (4.4 million children) were 
enrolled in 35 S-SCHIP programs.6      
By design, Medicaid aims at covering the “uninsurable” and thus attracts CSHCNs.7    Research 
shows that children who have Medicaid are more likely to be only in fair or poor health, as 
reported by their parents, have asthma, learning disorders, or medical conditions that require 
regular treatment with prescription drugs.8   The program has characteristics that make it, at 
least in theory, a great policy for children, particularly CSHCNs, even though access to 
physicians willing to participate in the program has been problematic since the program’s 
inception due to reimbursement levels that are low relative to what other payers, such as 
Medicare and commercial insurers, pay for the same service. Medicaid law creates an individual 
entitlement to a federally-defined comprehensive set of benefits with no cost-sharing allowed.  It 
requires coverage of medically necessary services for children even if they do not restore these 
children’s normal functioning, but rather maintain current functioning or prevent further 
deterioration from normal functioning, and even if they are not specifically listed in the state 
Medicaid plan.  When benefits are further denied, beneficiaries can rely on a federally-
determined fair hearing process to seek redress. When state agencies deliver services through 
managed care organizations or MCOs (as is the case for the majority of women and children), 
services not provided by the insurer remain the responsibility of the Medicaid agency.9   
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In contrast, by design, S-SCHIP functions more like a private insurance policy and thus 
addresses the needs of generally “healthy” children.10    It is not an entitlement to individual 
children, and benefits may be less comprehensive in scope, amount and duration than Medicaid 
benefits, with some cost-sharing allowed.  The medical necessity standard can be more 
restrictive than the “preventive” medical necessity standard used in Medicaid, limiting coverage 
of services to those that are restorative.  Grievances and appeals may be less defined.  And 
services not provided by MCOs must be found elsewhere in the system, e.g., through state 
public health agencies.11    
While SCHIP is still in the early years of implementation, the literature on its design and its 
impact on access and use of services is growing.   Early national benefit design studies conducted 
under the auspices of the Children’s Health Insurance Initiative (CHIRI)12  and elsewhere 
document that S-SCHIP programs tend to cover a range of benefits somewhat less broad than 
that available through Medicaid (particularly with respect to long-term care services) and 
employ coverage limits (such as limits on the number of visits for services to treat mental illness 
or developmental disabilities) that would not be permissible under Medicaid in the case of 
children.13  These studies suggest that the departure of S-SCHIP programs from the more 
generous coverage principles of Medicaid may mean that these programs may not be as 
responsive to the needs of CSHCNs as Medicaid can be. 
More recent studies of nationally representative data examine the effect of SCHIP on coverage 
and utilization,14 but few focus specifically on CSHCNs.15   For example, one study found that 
unmet need for dental care decreased and the probability of having a dental care visit increased 
for CSHCNs after their enrollment into SCHIP, consistent with the findings of similar studies 
on children generally.16   Such associations were not found to be statistically significant for 
specialty care and other services, again consistent with the findings of similar studies on children 
generally.17    Although this and other nationally representative studies did not distinguish 
between children’s enrollment in a SCHIP Medicaid expansion program and in a separately-
administered SCHIP program, state-based studies on S-SCHIP programs also suggest significant 
gains in dental care for children generally.18   
Other, state-based CHIRI studies of S-SCHIP programs examining the characteristics of the 
children enrolled in these programs, key indicators of access to care, disenrollment patterns, and 
reasons for leaving the programs, found that the prevalence of CSHCNs ranged from 17 to 25 
percent in Florida, Kansas, and New York.19    The authors conclude that this prevalence is 
slightly higher than the estimate of 13 to 18 percent of the general child population who is at 
risk of a chronic condition or has a higher than average need for services, and somewhat lower 
than the prevalence of special needs in Medicaid, confirming the need to take a closer look at 
access to services and quality of services rendered to these children under programs such as S-
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SCHIP that typically limit or exclude the types of services they need to maintain their 
functioning or prevent further deterioration of their health status.20      
Although national expenditure data on SCHIP-enrolled CSHCNs are not yet widely available, 
one would expect to find that, while these children constitute only a small proportion of 
enrolled children as is the case in any public or private plan, they nevertheless generate a 
disproportionate amount of the expenses incurred, further underscoring the importance of 
studying state efforts to monitor the quality of care received by CSHCNs.21     One study 
comparing two state separate SCHIP programs suggests this inverse relationship to be the case, 
showing that CSHCNs made up approximately 15% of the total enrollment but accounted for 
about 60% of the program expenditures.22    
Similarly, few studies have examined private and public insurers’ coverage decisionmaking and 
how it affects children generally and CSHCNs specifically,23   and none have studied this aspect 
of the SCHIP program, except for a handful of studies describing the medical necessity standards 
used in the program.24    Past studies focused on discrete aspects of the process: the use of 
information in the process;25  the process used by private and public payors to remedy lack of 
consensus on the evidence;26  the role of courts in reviewing coverage decisions;27  and the 
coverage of new technologies.28    But most relevant to this study are studies that explored the 
variation among private and public insurers in the coverage of specific treatments in relation to 
existing evidence, although very few focused on children’s health services.  For example, 
Finkelstein et al. found variations among private and public insurers and physicians regarding the 
coverage of growth hormone therapy for childhood short stature.29    Existing studies generally 
conclude that there is a high variation in decision outcomes among and within types of insurers 
(i.e., private insurers, Medicaid agencies).   
In this study, we explore how the variability in coverage and benefits found in S-SCHIP 
programs may influence children’s access to care by examining insurers’ coverage decisionmaking 
of a select number of services most needed by CSHCNs, including long-term therapies and 
support services.  The differences in insurance design between Medicaid and SCHIP were the 
rationale for the study and we assumed that the limits (e.g., scaled back benefit packages, 
coverage limitations and exclusions, etc.) found in S-SCHIP programs would disproportionately 
affect CSHCNs.  We assumed a disproportionate effect on CSHCNs because, even though they 
constitute a fairly small proportion of all SCHIP enrollees, they are higher users of care and 
particularly of expensive services, so that restrictions would affect them more than the majority 
of children who are generally healthy. 
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METHODS 
This study has two main objectives.  The first is to summarize the coverage of benefits in 
separately-administered SCHIP programs13; the second is to present coverage decisions for two 
hypothetical cases of children with special needs by participating insurers in states with such S-
SCHIP programs, relating the outcomes of these decisions back to what states required as a 
matter of benefits and coverage rules. 
Study Design 
The study design was qualitative and consisted of case studies of coverage decisions by private 
insurers regarding a select number of medically necessary services prescribed for two hypothetical 
children with special needs, using a semi-structured telephone survey complemented by 
documentary analysis, both conducted between March and June 2002. Main decision outcomes 
were: the insurer would have provided the service without limits; the insurer might have 
provided the service, but only with some limits; the insurer would not have provided the service.  
Insurers were also asked for the basis for their decisions, if they imposed limitations or excluded 
a service altogether. 
Population Studied 
Purposive sampling, which is a non-probability method of sampling based on the researcher’s 
subjective selection, was used to select states that presumably represented the most significant 
departure from Medicaid.  Their use of separate managed care contracting documents for 
Medicaid and SCHIP services was interpreted as signaling their intention to depart from the 
extensive specifications usually found in Medicaid managed care contracts and to more closely 
follow standard commercial contracts.  Fourteen states fit this criterion as of 2002.  Although 
these states constituted a non-representative sample of S-SCHIP programs, together they 
covered 66 percent of all S-SCHIP enrolled children and were spread across all four main 
regions of the country.30   Within these 14 states, we identified 71 medical directors employed 
by plans participating in both Medicaid and SCHIP who may potentially provide similar or 
differential treatment to their Medicaid and SCHIP members.   
Very few medical directors agreed to answer our short survey.  Only 13 percent of medical 
directors participated for a total of 234 coverage decisions; 49 percent explicitly declined; and 
38 percent did not respond after repeated requests.  Six of the 14 states were represented, which 
combined covered 46 percent of all children enrolled in S-SCHIP programs and all four main 
regions of the country.  The six states shared similar program characteristics to the other eight 
states not represented in the study in terms of their use of benefit exclusions and/or limitations 
(100%) and co-payments (50%), but they were more likely to use a restorative standard of 
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medical necessity or not have defined the standard of medical necessity in their contract (66% 
versus 50%), offer fewer managed care options to children (66% versus 25%), and include states 
that had all of these characteristics combined (33% versus 12.5%).  Insurers were represented at 
varying levels across the six states, from a low of 6 percent of all insurers in one state to a high of 
100 percent of insurers in another state.    
States are not named individually in order to protect the privacy of the respondents who agreed 
to participate in this study.31 
Data Collection and Analysis 
Data collection and analysis followed four main steps.  First, researchers used a database of 
SCHIP plan and contract language to analyze the extent of coverage of benefits more likely to 
be needed by CSHCNs in the 14 study states and to fine tune this analysis in the six states 
represented in the study.  These broad categories of benefits were: (1) medications; (2) speech 
and physical therapy; (3) durable medical equipment;  (4) enabling (i.e., non-medical, non-
emergency) transportation; and (5) case management to coordinate the children’s care.  The 
National Survey on Children with Special Health Care Needs found that almost all CSHCNs 
need prescriptions drugs, a quarter need physical and speech therapy, and 2-4% need 
communication and mobility aids.32   On average, the 14 states selected for participation in this 
study limited or excluded these benefits altogether.   
Second, researchers developed a list of 13 services that fall under these broad categories of 
benefits (Table 1).  Researchers also designed two vignettes (see boxes) of hypothetical children 
with conditions that are either long-term for which there is usually no return to a state of 
“normal functioning” (spina bifida) or very acute with the possibility of either long-term 
sequelae or a return to “normal functioning” (head trauma).  In both cases, however, the 
children described had special needs requiring specialized, and often expensive, treatment.  This 
information was the basis for the survey questions and for the analysis of findings across and 
within states, respectively.  
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Third, in telephone interviews, researchers used a structured interview script and presented the 
two patient scenarios to the medical directors who agreed to participate in the study, asking 
them to assume that each patient had SCHIP coverage and that her treating physician had 
recommended the provision of each of the 13 services listed in Table 1 as medically necessary 
and to make a coverage decision for each service based on these assumptions.   
Fourth, researchers compiled the information gathered through the interviews to present 
coverage decision outcomes in the form of aggregate findings. Although some simple statistical 
analyses were planned, it was not possible to perform them due to the very low number of 
responses.  However, researchers analyzed the results to delineate patterns across the interviews 
regarding potential similarities and differences in coverage decision outcomes. 
 
 
Patient Scenario A: Spina Bifida 
Case of a six-year -old with spina 
bifida,  hydrocephalus,  shunt in 
the brain to treat  the 
hydrocephalus,  neuro-
developmental  delay,  paralysis of 
the lower extremit ie s,  hearing 
loss,  and failure to thrive.    
Most frequently occurring permanently 
disabling birth defect; 1 out of every 
1,000 newborns annually.  Potential 
need for surgeries and extensive medical 
care; bowel and bladder complications, 
hydrocephalus, learning disabilities, 
physical limitations, emotional 
problems. 
 
Patient Scenario B: Head Trauma 
Case of an otherwise heal thy 
seven-year-old crit i cal ly injured in 
a motor vehicle crash,  with 
mult iple long bone fractures,  
pulmonary injuries,  significant 
facial  and dental  injuries,  hearing 
loss,  and closed head injury.  
Approximately 2 million per year, 
including 500,000 severe enough to 
require hospitalization, and 99,000 
resulting in a lasting disability; traffic 
accidents account for 1/3rd-1/2; common 
among children.  Potential changes in 
personality, emotions or mental abilities, 
speech and language problems, loss of 
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RESULTS 
In this section, we integrate findings from the state plan and contract language analysis with 
findings from the telephone interviews.  We found that the study states’ separate SCHIP 
programs varied in the types of limits or exclusions they imposed on benefits but generally agreed 
on which benefits to limit or exclude.  Insurers who participated in this study, on the other 
hand, exhibited tremendous variation in coverage decision outcomes.  In addition, they would 
have exercised discretion in deciding whether SCHIP-enrolled CSHCNs would obtain coverage 
of services deemed essential to these children, which translated into both more generous and 
more limited coverage than state prescribed coverage depending on the service and the case 
scenario involved. 
States’ Coverage of Medically Necessary Services under S-SCHIP 
State SCHIP programs were generally more restrictive than Medicaid for all services we 
examined.  All agreed that enabling transportation should be excluded, and they all limited the 
other 12 services in some way.  The only disagreement in coverage among states related to case 
management/care coordination, but the majority still limited (three states) or excluded (two 
states) this service.  In contrast, all of the study states’ Medicaid managed care contracts covered 
the Early and Periodic Screening, Diagnosis, and Treatment (EPSDT) benefit (i.e. the child 
benefit under Medicaid) and used a preventive medical necessity standard to determine coverage 
of specific services under EPSDT.  As a result of these broad coverage standards in the case of 
children, these state Medicaid programs cover medically necessary services regardless of whether 
they are specifically listed in the state Medicaid plan.   
The majority of state SCHIP agencies in this study did not define the medical necessity standard 
that would apply to determine whether a covered service is medically necessary for an individual 
child, and thus delegated this responsibility to participating insurers.  Our findings describe the 
coverage outcomes of insurers applying their internal standard of medical necessity to the 
services listed in Table 1 for two hypothetical children. 
Insurers’ Coverage of Medically Necessary Services under S-SCHIP 
Variat ion in the Level  of  Agreement among Insurers.   As in previous research, we 
found a high level of variation among insurers.  This variation, however, was the exact opposite 
of states’ variation in coverage.   More specifically, unlike states, insurers were far from being in 
agreement on any specific service, with the exception of the coverage of a case manager to 
coordinate the care of the child suffering from head trauma where 100 percent of the 
interviewees agreed they would have covered it without any limitations.    The second highest 
level of agreement was 89 percent for full coverage of speech and language evaluation for both 
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children, and a case manager to coordinate the care of the child with spina bifida, and for limited 
coverage of speech therapy for the child with head trauma.  The lowest level of agreement was 
for assistive communication devices and enabling transportation.  Table1 displays this variation 
in greater detail. 
Breadth of Coverage.   Despite the variation just described, the majority of insurers made up 
for the limitations of the S-SCHIP benefit package designed by states and reflected in their 
contracts and would have provided coverage beyond the limits and exclusions of S-SCHIP for 
the majority of services examined here.  This was particularly true for case management/care 
coordination for both children, which almost all insurers would have covered without 
limitations, when states limited or excluded this service.  This was also the case for both children 
for the three prescription drugs studied, speech and language evaluation, hearing aids, fitted 
wheelchairs, and pumps for overnight feedings, which two-thirds of the insurers would have 
covered without limits (compared to states that unanimously limited these services).  Finally, 
insurers were also more generous in their coverage of enabling transportation than states, all of 
which excluded coverage of this service, albeit with some more variation (about a third would 
have covered it without limits and another fifth with some limits). 
This finding would indicate that insurers may provide, perhaps routinely, extra-contractual 
services by overriding otherwise applicable limits in the case of higher needs children, even 
though the premium they receive is not calibrated to tolerate this type of practice. 
On the other hand, certain services most needed by CSHCNs, such as speech and physical 
therapy, motorized wheelchairs, and assistive communication devices, were generally restricted 
under S-SCHIP by both states and insurers in ways permissible under S-SCHIP but not 
permissible under Medicaid in the case of children.  In addition, several insurers also excluded 
these services, seemingly against what the SCHIP programs called for.  Table 1 shows this in 
greater detail. 
Coverage Exclusions.   Because of the discrepancy between insurers and states in coverage 
levels, particularly in the area of exclusions, we examined exclusions only and how they varied by 
condition.  A relatively small proportion of all coverage decisions (n=234) are exclusions (27 or 
11.5 percent).  And it appears that the less acute the condition suffered by the child, the more 
frequently insurers would have imposed exclusions.  Nine percent of all decisions related to the 
care needed by the child with a head trauma were exclusions, compared to 14 percent of all 
decisions related to the care needed by the child with spina bifida.  
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Services more likely to be targeted for exclusion included speech and physical therapy for the 
child with spina bifida.  Insurers based their decisions on the fact that the therapies would not 
have been restorative and thus did not fit the criteria for coverage.   
Because there were variations in exclusions within states also, we examined discrepancies 
between an individual insurer’s decision to exclude a service and that insurer’s state 
requirements to cover it, whether with limits or none at all, as spelled out in the managed care 
contract.  In four states, there were four services, where this inconsistency was noted for one or 
both children: (1) assistive communication devices for both children (in four states for the child 
with spina bifida, and in three states for the child with head trauma), (2) speech therapy for the 
child with spina bifida in two states, (3) hearing aids for the child with spina bifida in two states, 
and (4) motorized wheelchairs for both children in one state.  Thus, in these four states, it is 
possible that insurers would have excluded services when these services arguably should have 
been covered according to the language used in the contracting documents.  
In one state in particular, the language leaves little doubt that the sole insurer in that state 
should have covered assistive communication devices for both children instead of excluding them 
because, the insurer explained, they are not covered in the SCHIP program and it has to 
administer the benefits “as is contracted.”  However, a closer examination of the contract in 
question shows that it stipulates that durable medical equipment should be covered when 
medically necessary, it does not contain any exclusions, and it provides a definition of medical 
necessity that follows the Medicaid pediatric preventive standard of medical necessity.  
Interestingly, this state is one of the only two states in this study that actually specified a 
preventive medical necessity standard in the contract.   
In comparison, in the remaining three states, the language is somewhat ambiguous and subject 
to interpretation.  In one of these three states, which imposes many limitations and exclusions 
on services, the contract includes an interesting provision on CSHCNs that would seem to 
override all limitations because it explicitly lists spina bifida and hydrocephalus as qualifying 
conditions and requires timely access to a number of services, including rehabilitation and 
durable medical equipment appropriate for the condition.  But in this state, as in the other two 
states, the contract does not define medical necessity, in effect delegating that responsibility to 
insurers and thus relying on more normative insurance principles that emphasize standard 
coverage rules and support the exclusion of services for children with low prevalence conditions, 
and deemphasize the unique coverage principles of Medicaid for children, which favor the 
coverage of services for children with low prevalence problems. 
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The question that remains unanswered by this research is whether, in these four states, the child 
would have obtained coverage for the service on appeal, and if not, whether the state remains 
obligated to furnish this service as is the case in Medicaid. 
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DISCUSSION 
 
This study of mandated versus implemented benefits for S-SCHIP-enrolled CSHCNs compares 
a selected number of benefits covered at the macro level in the state SCHIP plans and managed 
care contracts with the micro decisions of insurers, who decide on a case-by-case basis whether 
these benefits are medically necessary for a specific child. 
This study is significant because it provides new knowledge on how the process works (or does 
not work) for CSHCNs who have public insurance that closely follows commercial rules and 
what it means for these children’s access to care, which is based on information that is difficult 
to obtain in nationally representative surveys or at the state level because of the small number of 
cases involved and because of the need to distinguish between enrollment in Medicaid and S-
SCHIP programs.  It also illustrates what publicly-financing insurance programs may look like in 
the near future as federal and state policymakers discuss whether to reform Medicaid in the form 
of increased flexibility to states.   
Overall, insurers would have provided coverage beyond the limits and exclusions of SCHIP 
when in fact payment received does not account for these extra-contractual services.  This 
became apparent for services, such as prescription drugs and support services.  There were some 
notable exceptions, however, which led to the exclusion of important services, such as therapies 
and durable medical equipment, which suggest that coverage at current levels may not be 
sufficient to care for CSHCNs.  These findings support our assumption that the variability in 
coverage and benefits found in S-SCHIP programs as a result of states exercising their flexibility 
to depart from Medicaid can influence access to care by CSHCNs, and are consistent with 
previous research findings.   
However, this study also has several limitations that require caution in interpreting the results.  
First, the sample of states is not a representative sample, and thus findings are not generalizable 
to all states with separate SCHIP programs.  Although the findings may not be generalizable, 
they provide important insights for the future of the Medicaid and SCHIP programs, as more 
states can be expected to move toward a commercial insurance model for the provision of 
services to children.  Second, the number of responses from the interviews is very small, raising 
issues of response bias and problems of analysis.  Even with the small number of responses, 
however, some patterns were detectable and, as such, were interpreted as indicative of the larger 
picture.  Third, the cases presented to the medical directors for a coverage decision described 
hypothetical cases of children with special needs.  While this is obviously different from real-life 
cases, the scenarios aimed at representing realistic situations and capturing dilemmas 
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encountered in the real world.  Nevertheless, the results represent a qualitative indication of 
what may be happening on the ground.  Furthermore, this type of research is the only one that 
can reach the level of analysis necessary to detect any differences.  Large population-based and 
claims-based datasets may not capture sufficient data to address these questions due to the rarity 
of the medical conditions, the types of services, and the small numbers of decisions involved. 
Our findings have two main implications.  First, they point to the need to include protections 
for CSHCNs so that the potential for denial of treatment or serious undertreatment can be 
reduced or preferably avoided.  The majority of our study states did not specify a standard of 
medical necessity in their SCHIP plan and contract and could include such a standard in these 
documents that either adopts the “preventive” definition of the Medicaid program or some 
similar definition. 
However, as this research suggests, reinstating a preventive medical necessity standard in SCHIP 
may not be sufficient to ensure access to needed care, so that the availability of external reviews 
of insurers’ coverage decisions becomes an important component of SCHIP program design 
because some services denied may actually be covered on appeal. Among the study states, all but 
one state specified in their SCHIP plan, their managed care contract, or both, an external right 
of appeals, but none gave individuals a right to a fair hearing.  Ensuring that SCHIP moves 
toward the adoption of rules similar to the Medicaid fair hearing rules would mostly affect 
CSHCNs, who would greatly benefit from improved access to services.   
If benefits are further denied on appeal, the availability of, and the coordination with, other 
sources of care becomes all the more important so that CSHCNs can be referred to these other 
sources, which may be able to provide or reimburse needed care if eligible.  States could lessen 
the impact of leaner benefit packages under SCHIP by establishing some kind of a wrap around 
system of services, which can be administered jointly by the SCHIP agency and other agencies in 
the state, such as public health agencies.  In fact, two of the states represented in this study have 
already done so.  One state has a specialty care carve-out (i.e., all specialty services are provided 
through a program separate from SCHIP), and another state has a person carve-out (i.e., the 
child is referred to a specialized system of care that provides the full range of services).  A third 
alternative not represented in this study but adopted by a few other states consists of creating a 
benefit package that supplements the SCHIP benefit package and provides coverage beyond the 
limits and exclusions imposed in SCHIP.  If unable to establish a wrap around system of 
services, states may want to consider strengthening their coordination efforts with these other 
public health agencies in the state that have traditionally cared for CSHCNs.  These agencies 
include the state Title V CSHCNs agencies, a logical source of funding for children with 
extremely serious physical disabilities and conditions, and other agencies, such as those running 
special education programs, state block grants for mental illness and mental retardation, and 
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other grant-style programs, which provide services for children with mental and developmental 
disabilities and delays not funded by most Title V programs.  Several states, including at least 
one of the study states, have undertaken such efforts from the outset but they are far from being 
the overwhelming majority.   Coordination between SCHIP and these other sources of care, 
both at the program design and program implementation stages, becomes of the utmost 
importance in ensuring that CSHCNs gain access to the services they need. 
Second, since insurance design seems to matter in terms of access to health care for CSHCNs 
and since insurance products that are limited in their coverage of treatment and management of 
chronic conditions and illnesses appear to affect the extent to which children with serious health 
problems use care, additional research on the actual use of services, comparing SCHIP-covered-
CSHCNs with similarly situated children enrolled in Medicaid, is needed to examine how these 
children fare on the ground.  This research could test for health care differences that can be 
linked to the nature, quality and structure of children’s insurance coverage, and determine 
whether key indicators of access differ significantly depending on the type of coverage. 
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CONCLUSION 
In conclusion, SCHIP has advantages and disadvantages.  On the one hand, the flexibility in 
program design under SCHIP allows states to extend coverage to higher family income levels 
and thus a higher number of uninsured children than they would have otherwise, had they not 
been able to exercise more control over the specific terms for providing that coverage.  At the 
same time, the ability to use more limited benefit packages and higher cost-sharing, mandatory 
managed care enrollment for all children, and, when financially necessary, coverage waiting lists 
permits to exercise greater restraint over expenditures under the program. 
On the other hand, this discretion has important implications for certain groups of children, i.e., 
those who find themselves on waiting lists for any coverage, as well as CSHCNs whose health 
conditions place them beyond the limits of the coverage they receive.  It is this second group in 
which we were interested in this study because of concerns that shortfalls in coverage for care 
could lead to insufficient access to medically necessary treatment and management services.  
This concern with the impact of more limited SCHIP products on CSHCNs has taken on 
additional importance because of evidence of movement in the underlying Medicaid program 
toward more limited benefits and higher cost-sharing through legislative reform or the use of 
regulatory waiver demonstration authority. It is important to know whether supplemental 
services or insurance would be necessary for certain children were coverage to be curtailed and, if 
so, for which children coverage and treatment supplements would be most significant.  
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Table 1.  Frequency Distribution 
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   No. of states (n=6) that… No. of insurers (n=9) that… 
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(*) Two states did not know whether enabling transportation was covered in their contract. 
Source: CHSRP, 2002. 
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